DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
FRA:DMP - Deutsche Boerse Ag - DE000A2GS5D8 - Common Stock - Currency: EUR
We assign a fundamental rating of 4 out of 10 to DMP. DMP was compared to 52 industry peers in the Pharmaceuticals industry. DMP has a medium profitability rating, but doesn't score so well on its financial health evaluation. DMP is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year DMP was profitable.
In the past year DMP had a positive cash flow from operations.
In the past 5 years DMP has always been profitable.
In the past 5 years DMP always reported a positive cash flow from operatings.
1.2 Ratios
DMP's Return On Assets of 4.27% is in line compared to the rest of the industry. DMP outperforms 53.85% of its industry peers.
DMP has a better Return On Equity (15.52%) than 73.08% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.98%, DMP is in line with its industry, outperforming 51.92% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DMP is below the industry average of 13.62%.
The last Return On Invested Capital (6.98%) for DMP is well below the 3 year average (11.59%), which needs to be investigated, but indicates that DMP had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 15.52% | ||
| ROIC | 6.98% |
ROA(3y)9.09%
ROA(5y)8.34%
ROE(3y)26.32%
ROE(5y)26.66%
ROIC(3y)11.59%
ROIC(5y)10.03%
1.3 Margins
DMP has a Profit Margin (7.82%) which is in line with its industry peers.
DMP's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 17.78%, DMP perfoms like the industry average, outperforming 55.77% of the companies in the same industry.
In the last couple of years the Operating Margin of DMP has declined.
DMP's Gross Margin of 64.66% is on the low side compared to the rest of the industry. DMP is outperformed by 61.54% of its industry peers.
In the last couple of years the Gross Margin of DMP has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.78% | ||
| PM (TTM) | 7.82% | ||
| GM | 64.66% |
OM growth 3Y-0.55%
OM growth 5Y-2.38%
PM growth 3Y-20.2%
PM growth 5Y-16.03%
GM growth 3Y2.75%
GM growth 5Y3.88%
2. Health
2.1 Basic Checks
DMP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, DMP has about the same amount of shares outstanding.
DMP has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, DMP has a worse debt to assets ratio.
2.2 Solvency
DMP has an Altman-Z score of 2.11. This is not the best score and indicates that DMP is in the grey zone with still only limited risk for bankruptcy at the moment.
DMP has a Altman-Z score (2.11) which is in line with its industry peers.
The Debt to FCF ratio of DMP is 6.53, which is on the high side as it means it would take DMP, 6.53 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DMP (6.53) is comparable to the rest of the industry.
DMP has a Debt/Equity ratio of 1.55. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.55, DMP is doing worse than 69.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.55 | ||
| Debt/FCF | 6.53 | ||
| Altman-Z | 2.11 |
ROIC/WACC1.2
WACC5.84%
2.3 Liquidity
DMP has a Current Ratio of 1.66. This is a normal value and indicates that DMP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DMP (1.66) is better than 69.23% of its industry peers.
A Quick Ratio of 0.74 indicates that DMP may have some problems paying its short term obligations.
DMP has a Quick ratio of 0.74. This is amonst the worse of the industry: DMP underperforms 82.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.66 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
The earnings per share for DMP have decreased by -4.71% in the last year.
Measured over the past years, DMP shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.85% on average per year.
DMP shows a small growth in Revenue. In the last year, the Revenue has grown by 0.16%.
Measured over the past years, DMP shows a quite strong growth in Revenue. The Revenue has been growing by 14.68% on average per year.
EPS 1Y (TTM)-4.71%
EPS 3Y-10.1%
EPS 5Y-3.85%
EPS Q2Q%29.99%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y12.67%
Revenue growth 5Y14.68%
Sales Q2Q%9.54%
3.2 Future
DMP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.17% yearly.
Based on estimates for the next years, DMP will show a small growth in Revenue. The Revenue will grow by 3.86% on average per year.
EPS Next Y-9.07%
EPS Next 2Y2.26%
EPS Next 3Y5.17%
EPS Next 5YN/A
Revenue Next Year5.63%
Revenue Next 2Y4.81%
Revenue Next 3Y4.6%
Revenue Next 5Y3.86%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 23.36, the valuation of DMP can be described as rather expensive.
The rest of the industry has a similar Price/Earnings ratio as DMP.
Compared to an average S&P500 Price/Earnings ratio of 29.35, DMP is valued a bit cheaper.
The Price/Forward Earnings ratio is 16.77, which indicates a correct valuation of DMP.
DMP's Price/Forward Earnings ratio is in line with the industry average.
DMP is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.36 | ||
| Fwd PE | 16.77 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DMP is valued a bit cheaper than 71.15% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DMP is valued cheaper than 80.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.45 | ||
| EV/EBITDA | 9.99 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.26%
EPS Next 3Y5.17%
5. Dividend
5.1 Amount
DMP has a Yearly Dividend Yield of 2.25%.
Compared to an average industry Dividend Yield of 2.86, DMP pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, DMP has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.25% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
52.30% of the earnings are spent on dividend by DMP. This is a bit on the high side, but may be sustainable.
DP52.3%
EPS Next 2Y2.26%
EPS Next 3Y5.17%
FRA:DMP (3/7/2025, 7:00:00 PM)
39.25
+0.2 (+0.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners16.9%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.11B
Analysts80
Price Target48.58 (23.77%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.25% |
Yearly Dividend1.05
Dividend Growth(5Y)N/A
DP52.3%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.36 | ||
| Fwd PE | 16.77 | ||
| P/S | 1.82 | ||
| P/FCF | 13.45 | ||
| P/OCF | 10.74 | ||
| P/B | 3.62 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.99 |
EPS(TTM)1.68
EY4.28%
EPS(NY)2.34
Fwd EY5.96%
FCF(TTM)2.92
FCFY7.43%
OCF(TTM)3.65
OCFY9.31%
SpS21.52
BVpS10.84
TBVpS-9.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 15.52% | ||
| ROCE | 11.79% | ||
| ROIC | 6.98% | ||
| ROICexc | 7.52% | ||
| ROICexgc | 23.22% | ||
| OM | 17.78% | ||
| PM (TTM) | 7.82% | ||
| GM | 64.66% | ||
| FCFM | 13.56% |
ROA(3y)9.09%
ROA(5y)8.34%
ROE(3y)26.32%
ROE(5y)26.66%
ROIC(3y)11.59%
ROIC(5y)10.03%
ROICexc(3y)13.3%
ROICexc(5y)11.46%
ROICexgc(3y)31.72%
ROICexgc(5y)27.51%
ROCE(3y)19.57%
ROCE(5y)16.95%
ROICexcg growth 3Y5.64%
ROICexcg growth 5Y-17.34%
ROICexc growth 3Y-5.34%
ROICexc growth 5Y-17.44%
OM growth 3Y-0.55%
OM growth 5Y-2.38%
PM growth 3Y-20.2%
PM growth 5Y-16.03%
GM growth 3Y2.75%
GM growth 5Y3.88%
F-Score6
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.55 | ||
| Debt/FCF | 6.53 | ||
| Debt/EBITDA | 3 | ||
| Cap/Depr | 41.77% | ||
| Cap/Sales | 3.42% | ||
| Interest Coverage | 3.83 | ||
| Cash Conversion | 65.36% | ||
| Profit Quality | 173.43% | ||
| Current Ratio | 1.66 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | 2.11 |
F-Score6
WACC5.84%
ROIC/WACC1.2
Cap/Depr(3y)72.39%
Cap/Depr(5y)81.63%
Cap/Sales(3y)4.65%
Cap/Sales(5y)5.14%
Profit Quality(3y)186.68%
Profit Quality(5y)147.28%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.71%
EPS 3Y-10.1%
EPS 5Y-3.85%
EPS Q2Q%29.99%
EPS Next Y-9.07%
EPS Next 2Y2.26%
EPS Next 3Y5.17%
EPS Next 5YN/A
Revenue 1Y (TTM)0.16%
Revenue growth 3Y12.67%
Revenue growth 5Y14.68%
Sales Q2Q%9.54%
Revenue Next Year5.63%
Revenue Next 2Y4.81%
Revenue Next 3Y4.6%
Revenue Next 5Y3.86%
EBIT growth 1Y-7.46%
EBIT growth 3Y12.04%
EBIT growth 5Y11.94%
EBIT Next Year52.94%
EBIT Next 3Y19.74%
EBIT Next 5Y9.41%
FCF growth 1Y-29.2%
FCF growth 3Y24.78%
FCF growth 5Y5.87%
OCF growth 1Y-26.77%
OCF growth 3Y18.33%
OCF growth 5Y6.56%